The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2017

Filed:

Nov. 02, 2011
Applicants:

Luigi Aurisicchio, Rome, IT;

Gennaro Ciliberto, Rome, IT;

Rita Mancini, Rome, IT;

Emanuele Marra, Pomezia, IT;

Guiseppe Roscilli, Rome, IT;

Inventors:

Luigi Aurisicchio, Rome, IT;

Gennaro Ciliberto, Rome, IT;

Rita Mancini, Rome, IT;

Emanuele Marra, Pomezia, IT;

Guiseppe Roscilli, Rome, IT;

Assignee:

TAKIS S.R.L., Rome, IT;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/30 (2006.01); C07K 14/705 (2006.01); A61K 38/17 (2006.01); A61K 39/00 (2006.01); C07K 14/71 (2006.01); C07K 16/32 (2006.01); A61K 45/06 (2006.01); A61K 31/7088 (2006.01);
U.S. Cl.
CPC ...
C07K 14/705 (2013.01); A61K 31/7088 (2013.01); A61K 38/179 (2013.01); A61K 39/0011 (2013.01); A61K 45/06 (2013.01); C07K 14/71 (2013.01); C07K 16/32 (2013.01); A61K 2039/507 (2013.01); A61K 2039/53 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01);
Abstract

The present invention describes methods and pharmaceutical compositions for the treatment of cancer in mammals, more particularly in human subjects. More specifically, the invention concerns anti-tumor vaccines based upon plasmid DNA and/or genetic vectors carrying a codon-usage optimized sequence and coding for a mutant form of the ErbB-3 receptor. Furthermore, the invention refers to monoclonal antibodies directed against the ErbB-3 receptor, obtained using these methods and capable to block its activity in cancer cells.


Find Patent Forward Citations

Loading…